NDC 62049-286 – Cladribine
Cladribine 10 mg/1 · Tablet · Oral
Product NDC62049-286
Product details
- Brand name
- Cladribine
- Generic name
- Cladribine
- Labeler
- Genvion Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA218425
- Marketed since
- November 25, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Purine Antimetabolite
Active ingredients
- Cladribine 10 mg/1
Package NDC codes (7)
| Package NDC | Description | Since |
|---|---|---|
| 62049-286-04 | 4 TABLET in 1 CARTON (62049-286-04) | Nov 25, 2025 |
| 62049-286-05 | 5 TABLET in 1 CARTON (62049-286-05) | Nov 25, 2025 |
| 62049-286-06 | 6 TABLET in 1 CARTON (62049-286-06) | Nov 25, 2025 |
| 62049-286-07 | 7 TABLET in 1 CARTON (62049-286-07) | Nov 25, 2025 |
| 62049-286-08 | 8 TABLET in 1 CARTON (62049-286-08) | Nov 25, 2025 |
| 62049-286-09 | 9 TABLET in 1 CARTON (62049-286-09) | Nov 25, 2025 |
| 62049-286-10 | 10 TABLET in 1 CARTON (62049-286-10) | Nov 25, 2025 |
Other Cladribine products
- 60505-4791 Cladribine 10 mg/1 · Tablet · Apotex Corp.
- 0781-8201 Cladribine 10 mg/1 · Tablet · Sandoz Inc.
- 63323-140 Cladribine 1 mg/mL · Injection · Fresenius Kabi USA, LLC
- 0143-9871 Cladribine 1 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 42658-010 Cladribine 1 mg/mL · Injection, Solution · Hisun Pharmaceuticals USA, Inc.